Segments - Additional Information (Details) |
9 Months Ended |
|---|---|
|
Sep. 30, 2026
Segment
| |
| Segment Reporting [Abstract] | |
| Number of reportable segment | 1 |
| Segment reporting, codm, profit (loss) measure, how used, description | The Company’s chief operating decision maker ("CODM") is the Chief Executive Officer. The CODM assesses performance for the drug development segment and decides how to allocate resources based on consolidated net loss that also is reported on the consolidated statement of operations. The CODM uses budget, forecast, and actual results of the consolidated net loss in deciding what drug development programs to further progress with its existing and planned capital resources. The measure of segment assets is reported on the balance sheet as consolidated assets. |
| Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration] | srt:ChiefExecutiveOfficerMember |